PofoliaShared via Pofolia

Proceedings of the National Academy of Sciences· 2026Q1

Intratumoral cDC1–T cell clusters serve as sites of local costimulation to enhance CTL-mediated tumor rejection

Catherine B. Carbone, Markus K. Brown, Camille-Charlotte Balança, Anthony C. Antonelli et al.

Short summary

Intratumoral clusters of type 1 conventional dendritic cells (cDC1s) and T cells, where cDC1s upregulate costimulatory molecules, promote tumor rejection, unlike tumors where cDC1s are excluded or migrate away.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Tumor rejection is determined by the spatial distribution of T cells and cDC1s, with co-infiltration (TC-In/DC-In) leading to rejection.
  • Intratumoral cDC1s in TC-In/DC-In tumors engage in direct interactions with T cells, upregulating costimulatory molecules.
  • cDC1s in TC-In/DC-Ex tumors exhibit gene expression suggesting a propensity to migrate out of the tumor.
  • Modulating chemokines (CXCL9, CCL5, XCL1) can promote intra-tumoral cDC1-T cell clustering and enhance tumor rejection.

AI-generated from the title and abstract; the full text is not read.

Abstract

Summary T cells are essential for anti-tumor immunity, but their ability to eliminate tumors depends on coordinated interactions with type 1 conventional dendritic cells (cDC1s). While cDC1s are known for cross-presenting tumor-derived antigens in lymph nodes to prime CD8+ T cells, their role within the tumor itself remains less well understood. Here, we use the Skin Tumor Array by Micro-Poration (STAMP) model to investigate how cDC1-T cell interactions shape immune responses and influence tumor fate. Our data reveal that it is the spatial distribution of both cDC1s and T cells that determines whether a tumor can be rejected. We defined three primary immunotypes based on the spatial distribution of T cells and cDC1s: T cell-inflamed/dendritic cell-inflamed (TC-In/DC-In) tumors, where T cells and cDC1s co-infiltrate the tumor; T cell-inflamed/dendritic cell-excluded (TC-In/DC-Ex) tumors, where T cells infiltrate but cDC1s remain at the periphery; and T cell-excluded/dendritic cell-excluded (TC-Ex/DC-Ex) tumors, which lack both cDC1 and T cell infiltration. Notably, TC-In/DC-In tumors are more likely to undergo rejection, whereas TC-In/DC-Ex tumors persist despite T cell infiltration. Within TC-In/DC-In tumors, cDC1s engage in direct interactions with T cells, upregulate co-stimulatory molecules, and sustain effector T cell responses, while cDC1s in TC-In/DC-Ex tumors express higher migration-associated genes, suggesting a propensity to exit the tumor. We further show that chemokine modulation, particularly through CXCL9, CCL5, and XCL1, can reshape immune infiltration patterns to promote intra-tumoral cDC1-T cell clustering and improve tumor rejection. These findings underscore the unexpectedly important role of cDC1 positioning and function in sustaining effective anti-tumor immunity and highlight spatially organized cDC1-T cell clusters as critical hubs for local T cell activation.

The authors' abstract, as published at the source. Proceedings of the National Academy of Sciences, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

ImmunologyImmunology and Microbiology